Ozempic 2025 Salesloft. Ozempic, with $8.3 billion in sales, is the leading novo nordisk product, accounting for 38.3% of the company’s total sales in 2022. It should not serve as an endorsement for the use of ozempic for.

Since the beginning of 2023, stock in ozempic maker novo nordisk is up around 75% versus about 40% for the s&p 500 index. A new poll finds many people may actually achieve their goals in 2025 — with a little help from their pharmacist.